GSK to buy cancer-focused IDRx in $1 billion deal The U.K. drugmaker has been trying to build up its cancer business

https://www.statnews.com/2025/01/13/gsk-idrx-gist-gastrointestinal-stromal-tumor-acquisition/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-_PwKRVtrveRifIJVBqNI7FQImPcdBgN2JWURnj4W4v5a33RbEU8SNtExGHgHYTrGe2HNmGvF0CzrrQpkxKB27PScyzMw&_hsmi=342313978&utm_content=342313978&utm_source=hs_email